A Commentary on “Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes”

A Commentary on “Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes”

Saved in:

Bibliographic Details
Main Author:	Toshihiko Inui
Format:	Article
Language:	English
Published:	Korean Spinal Neurosurgery Society 2025-03-01
Series:	Neurospine
Online Access:	http://e-neurospine.org/upload/pdf/ns-2550298-149.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes
by: Hyun Woong Mun, et al.
Published: (2025-03-01)

Diagnosis of skeletal fragility due to Loeys-Dietz syndrome and treatment with romosozumab followed by denosumab
by: Yasutaka Tsujimoto, et al.
Published: (2025-06-01)

A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis
by: Yasumori Sobue, et al.
Published: (2025-07-01)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
by: A. Sánchez, et al.
Published: (2016-01-01)

Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
by: Shejil KUMAR, et al.
Published: (2025-06-01)

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study
by: Hiroya Takami, et al.
Published: (2017-01-01)

A comparative analysis of Denosumab and Zoledronic acid effects on bone metabolism and bone mineral density in individuals with osteoporotic vertebral compression fractures
by: Gao Shouda, et al.
Published: (2025-01-01)

Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment
by: Shi-Hsun Chiu, et al.
Published: (2024-12-01)

A 3D printed hybrid vertebroplasty and screw augmentation teaching model simulating normal and osteoporotic bone mineral densities
by: S. Jeising, et al.
Published: (2024-01-01)

Efficacy of ketorolac versus tramadol for analgesia during percutaneous vertebroplasty
Published: (2024-10-01)

Clinical efficacy of romosozumab in the treatment of elderly male patients of osteoporotic with hip fractures: a retrospective study
by: Yichao Ji, et al.
Published: (2025-01-01)

Commentary: Negative association between Body Roundness Index and bone mineral density: insights from NHANES
by: Chenglong Wang, et al.
Published: (2025-03-01)

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01)

Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01)

Comparison of the effects of zoledronic acid versus denosumab on bone metabolism, inflammatory response, and immunoglobulins in breast cancer patients with bone metastases
by: Zhang Xian, et al.
Published: (2025-01-01)

Clinical outcome of vertebroplasty alone versus short-segment posterior instrumentation with vertebroplasty in osteoporotic vertebral fracture: a propensity-score-matched analysis
by: Borriwat Santipas, et al.
Published: (2025-02-01)

Risk factors and reasons for romosozumab nonadherence in a case-control study
by: Ting-Chien Tsai, et al.
Published: (2025-07-01)

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy
by: İrem Öner, et al.
Published: (2025-02-01)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
by: Ryan Carlisle Egbert, et al.
Published: (2017-01-01)

Bone Mineral Densities and Mechanical Properties of Retrieved Femoral Bone Samples in relation to Bone Mineral Densities Measured in the Respective Patients
by: Yvonne Haba, et al.
Published: (2012-01-01)

BONE MINERAL DENSITY IN SJOGREN'S DISEASE
by: N S Sliornikova, et al.
Published: (2002-06-01)

Bone Mineral Density in Ankylosing Spondylitis
by: Bahar Çakmak, et al.
Published: (2003-12-01)

Commentary: Bone Density in Women with Inflammatory Bowel Disease
by: A Hillary Steinhart
Published: (2004-01-01)

Related Biological Research in the Interface between Bone Cement and Bone after Percutaneous Vertebroplasty
by: ZhenMing Hu, et al.
Published: (2013-01-01)

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation
by: Elena Gonzalez-Rodriguez, et al.
Published: (2018-01-01)

Efficacy and safety of vertebroplasty versus posterior pedicle screw in treating stage III Kummell’s disease without neurological deficits: A systematic review and meta-analysis
by: Binbin Tang, et al.
Published: (2025-07-01)

The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment
by: Akira Horikawa, et al.
Published: (2024-01-01)

Novel injectable composite incorporating denosumab promotes bone regeneration via bone homeostasis regulation
by: Guang Yang, et al.
Published: (2024-12-01)

Assessment of bone density in children with cerebral palsy by areal bone mineral density measurement
by: Ihsan Esen, et al.
Published: (2011-12-01)

Bone mineral density and Trabecular Bone Score in children and adolescents
by: H.V. Beketova, et al.
Published: (2025-04-01)

Bone mineral density in elderly patients with osteoarthrosis
by: N V Mitrofanova, et al.
Published: (2008-12-01)

BONE MINERAL DENSITY AFTER LIVER TRANSPLANTATION
by: V. P. Buzulina, et al.
Published: (2010-06-01)

Bone mineral density in patients with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-03-01)

Effects of vegetarian diet on bone mineral density
by: Tzyy-Ling Chuang, et al.
Published: (2021-01-01)

Precooling storage of bone cement in percutaneous vertebroplasty for osteoporotic vertebral compression fracture
by: Shan-Wen Xiao, et al.
Published: (2024-12-01)

Exploring Denosumab’s potential in aneurysmal bone cyst treatment: A scoping review
by: Vinesh Sandhu, et al.
Published: (2024-10-01)

Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico.
by: Juan Pablo Diaz Martinez, et al.
Published: (2025-01-01)

Effect of Probiotics Supplementation on Bone Mineral Content and Bone Mass Density
by: Kolsoom Parvaneh, et al.
Published: (2014-01-01)

Association of bone mineral density and trabecular bone score with cardiovascular disease
by: Tzyy-Ling Chuang, et al.
Published: (2020-01-01)

THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01)